Tuesday, May 24, 2016

GeneNews closes note financing with Alumina

GeneNews closes note financing with Alumina

April 28, 2016 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has executed a definitive financing agreement with Alumina Partners for a second tranche of a non-brokered private placement. Under the accord, GeneNews will draw down on $10-million in structured, unsecured convertible notes, at the company’s option, in installments of $200,000 over a 24-month period. The initial draw will be limited to $200,000 […]

GeneNews provides financing update

GeneNews provides financing update

April 7, 2016 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has closed the first tranche of a private placement, consisting of the issuance of approximately 5.6 million common shares at a price of 10 cents each, for gross proceeds of approximately $560,000, to be used for working capital. The company also has executed a term sheet with Alumina Partners for a second […]

GeneNews arranging private placement

GeneNews arranging private placement

March 14, 2016 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) is undertaking a non-brokered private placement of up to 50 million common shares at a price of 10 cents apiece, or $5-million. Any remaining unfunded portion of the offering may be raised with the issuance of a senior secured, collateralized convertible debenture. If needed, this convertible debenture would be issued with a […]

GeneNews acquires full control of IDL

GeneNews acquires full control of IDL

March 4, 2016 by · Leave a Comment 

Tweet A GeneNews (TSX:GEN) U.S. subsidiary has agreed to acquire Cobalt Healthcare Consultants’ 50% interest in the Innovative Diagnostic Laboratory (IDL) joint venture so that GeneNews will have full ownership of IDL. Under the accord, GeneNews will assume Cobalt’s liability relating to its $1-million secured demand promissory note, payable to former IDL partner, HDL USA […]

GeneNews gets promising early results from lung cancer study

GeneNews gets promising early results from lung cancer study

September 8, 2015 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has received encouraging early results from the largest randomized trial ever conducted for the early detection of lung cancer using EarlyCDT-Lung, an autoantibody biomarker blood test. The findings were announced at the International Association for the Study of Lung Cancer’s World Conference on Lung Cancer. The National Health Service (NHS) Scotland-sponsored Early […]

GeneNews’ IDL to provide prostate testing to MD Anderson

GeneNews’ IDL to provide prostate testing to MD Anderson

September 4, 2015 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) Innovative Diagnostic Laboratory (IDL) joint venture has agreed to provide its prostate health index (PHI) testing services to MD Anderson Cancer Center. “There is significant interest in IDL’s early cancer diagnostic tests from hospital groups and large physician practice groups,” said James Howard-Tripp, executive chairman of GeneNews, said in a statement. “IDL […]

GeneNews in pact to increase stake in IDL venture

GeneNews in pact to increase stake in IDL venture

May 19, 2015 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has entered into a purchase agreement with Cobalt Healthcare Consultants to purchase Health Diagnostic Laboratory’s (HDL) one-third ownership stake in their Innovative Diagnostic Laboratory (IDL) joint venture for $4-million. Combined with prior investments in IDL, GeneNews and Cobalt will each own a 50% equity interest in the joint venture. GeneNews and Cobalt […]

Study finds colorectal cancer in young patients to double

Study finds colorectal cancer in young patients to double

November 17, 2014 by · Leave a Comment 

Tweet In the next 15 years, more than one-in-10 colon cancers and nearly one-in-four rectal cancers will be diagnosed in patients younger than the traditional screening age, according to researchers at The University of Texas MD Anderson Cancer Center. The growing public health problem is underscored by data trends among 20- to 34-year-olds in the […]

GeneNews’ IDL JV lab tests climb in Q3

GeneNews’ IDL JV lab tests climb in Q3

November 12, 2014 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) U.S. joint venture, Innovative Diagnostic Laboratory, processed more than 50,600 tests during the third quarter this year. With a successful limited scale launch of IDL’s operations in the fourth quarter of 2013, full scale up activities began in the first quarter this year, including growing IDL’s lab capacity, increasing the size and […]

GeneNews Q2 JV lab test volumes more than triple sequentially

GeneNews Q2 JV lab test volumes more than triple sequentially

August 8, 2014 by · Leave a Comment 

Tweet GeneNews’ (TSX:GEN) U.S. joint venture, Innovative Diagnostic Laboratory (IDL), processed 46,051 tests in the second quarter, up more than threefold sequentially from the 14,680 tests processed in the first quarter this year. “So far, that growth has continued into the third quarter,” GeneNews executive chairman James Howard-Tripp said in a statement. IDL’s menu of […]

Next Page »

Email Newsletters with Constant Contact
Google+